RepliCel Life Sciences, Inc. VS Pharmaceuticals: Major 
1D
50%
0.34%
1W
0%
2.68%
1M
50%
2.88%
YTD
-25%
15%
1Y
-72.73%
29.63%
3Y
-93.33%
76.61%
5Y
-94%
73.7%
10Y
-94%
151.63%
- Stock Absolute Returns
- S&P/TSX 60Absolute Returns
Price + DividendTotal Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
50.0%
0%
50.0%
6 Months
-72.73%
0%
-72.73%
1 Year
-72.73%
0%
-72.73%
2 Years
-90.0%
0%
-90.0%
3 Years
-93.33%
0%
-93.33%
4 Years
-96.1%
0%
-96.1%
5 Years
-94.0%
0%
-94.0%
RepliCel Life Sciences, Inc. for the last several years.
Risk Adjusted Returns v/s S&P/TSX 60Risk Adjusted Returns v/s
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
